Ready to Use Ketorolac Formulations

A pharmaceutical composition for parenteral administration comprising:

• an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount form about 0.1 mg/mL to about 10 mg/mL;
• and
• a pharmaceutically acceptable excipient
• wherein the formulation is substantially free of alcohol.
• a pharmaceutically acceptable excipient selected from the group consisting of anhydrous or hydrous forms of sodium chloride, dextrose, sucrose, xylitol, fructose, glycerol, sorbitol, mannitol, potassium chloride, mannose, calcium chloride, magnesium chloride;
• wherein the composition is substantially free of alcohol, has a pH from about 4.5 to about 8.5 and maintains at least 90% of the amount of ketorolac or a pharmaceutically acceptable salt thereof after storage for 6 months at 25° C.;
• and
• wherein the composition is contained in a pharmaceutically acceptable container selected from the group consisting of intravenous bags and intravenous bottles.